Stock PHO PHOTOCURE ASA
Add to a list
To use this feature you must be a member
Log inSign up

News Photocure ASA

Equities

PHO

NO0010000045

Market Closed - Oslo Bors
Other stock markets
 10:45:00 2024-05-10 am EDT 		5-day change 1st Jan Change
57.8 NOK -2.03% Intraday chart for Photocure ASA +4.14% -14.24%
Apr. 30 Photocure ASA Announces Pivotal Trial Results and New Real-World Evidence CI
Apr. 08 Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
AQ
Photocure ASA: Invitation to presentation of first quarter 2024 financial results
AQ
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
AQ
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
AQ
Photocure ASA: Annual Report 2023
AQ
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
AQ
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
AQ
Photocure ASA Announces Pivotal Trial Results and New Real-World Evidence
CI
Photocure ASA - Share option grant
AQ
Photocure ASA - European Association of Urology 2024 congress features new data on modern technology use in bladder cancer care
AQ
Photocure ASA Announces its Participation in the Congress, and Two Abstract Presentations at the 2024 European Association of Urology Congress in Paris, France
CI
Photocure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
AQ
Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference
AQ
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
AQ
Photocure ASA Announces the Publication of the Study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
CI
Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting
AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO
AQ
Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO
AQ
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHO Stock
  4. News Photocure ASA
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW